Gastro oesophageal cancer, Stomach cancer
Results
Phase 2
This trial was looking at 2 targeted cancer drugs called trastuzumab and pertuzumab and chemotherapy. It was for people:
with stomach cancer or cancer where the food pipe (oesophagus) meets the stomach (gastro oesophageal junction)
who had HER2 positive cancer. This means the cancer has large amounts of a protein called .
The trial was open for people to join between 2015 and 2021. The team presented their first results at a conference in 2023.
Recruitment start: 2 December 2016
Recruitment end: 31 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Bridgewater
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 01 Sept 2024
CRUK internal database number: 13571
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
